Christian Angermayer, Director, 10% Owner at ATAI Life Sciences N.V. (ATAI), bought 700,000 shares at $15.00 ($10.5M) on 2021-06-22, disclosed to the SEC on 2021-06-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ATAI | BUY | 2022-05-02 | $253K | — | Filing → |
| ATAI | BUY | 2022-04-28 | $617K | — | Filing → |
| ATAI | BUY | 2022-04-26 | $553K | — | Filing → |